Article
Posttranslational control of a cardiac ion channel transgene in vivo: clarithromycin-hMiRP1-Q9E interactions.
Human gene therapy - 1 Jul 2005
Perlstein Itay, Burton Denise Y, Ryan Kenneth, Defelice Suzanne, Simmers Erin, Campbell Barry, Connolly Jeanne M, Hoffman Amnon, Levy Robert J
Abstract excerpt
The present study investigates a novel gene therapy approach for atrial arrhythmias, using a clarithromycin-responsive ion channel subunit mutation, hMiRP1-Q9E, cloned into an expression plasmid; wild-type expression plasmids encoding human minK-related protein 1 (hMiRP1) were also used as controls. In a series of pig studies, right atrial myocardium was injected at one site with hMiRP1-Q9E plasmid DNA; a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
